Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117720

Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies.

Y F Khouri, K McIntosh, L Cavacini, M Posner, M Pagano, R Tuomala, and W A Marasco

Dana-Farber Cancer Institute, Division of Human Retrovirology, Boston, Massachusetts 02115.

Find articles by Khouri, Y. in: JCI | PubMed | Google Scholar

Dana-Farber Cancer Institute, Division of Human Retrovirology, Boston, Massachusetts 02115.

Find articles by McIntosh, K. in: JCI | PubMed | Google Scholar

Dana-Farber Cancer Institute, Division of Human Retrovirology, Boston, Massachusetts 02115.

Find articles by Cavacini, L. in: JCI | PubMed | Google Scholar

Dana-Farber Cancer Institute, Division of Human Retrovirology, Boston, Massachusetts 02115.

Find articles by Posner, M. in: JCI | PubMed | Google Scholar

Dana-Farber Cancer Institute, Division of Human Retrovirology, Boston, Massachusetts 02115.

Find articles by Pagano, M. in: JCI | PubMed | Google Scholar

Dana-Farber Cancer Institute, Division of Human Retrovirology, Boston, Massachusetts 02115.

Find articles by Tuomala, R. in: JCI | PubMed | Google Scholar

Dana-Farber Cancer Institute, Division of Human Retrovirology, Boston, Massachusetts 02115.

Find articles by Marasco, W. in: JCI | PubMed | Google Scholar

Published February 1, 1995 - More info

Published in Volume 95, Issue 2 on February 1, 1995
J Clin Invest. 1995;95(2):732–737. https://doi.org/10.1172/JCI117720.
© 1995 The American Society for Clinical Investigation
Published February 1, 1995 - Version history
View PDF
Abstract

Almost all childhood HIV-1 is now acquired through vertical transmission. Identifying factors that affect the rate of transmission may lead to the initiation of specific preventive strategies. In this study, antibody levels against different neutralizing epitopes on the envelope glycoprotein of HIV-1 (gp120) were measured in HIV-1-infected pregnant women that either transmitted HIV-1 to their infants (18 women) or did not (29 women). Differences in levels of antibodies directed against the monomeric gp120 molecule and against the V3 loop region of gp120 were not significantly different between the two groups studied. However, significant differences were observed in the levels of CD4 binding site antibodies, as determined by the ability of diluted maternal plasma to inhibit binding of the CD4 binding site monoclonal antibody F105 (mAb F105) to monomeric gp120. In addition, more nontransmitting mothers had low viral load as defined by having two or more negative HIV-1 viral cultures during pregnancy compared with transmitters. This pilot study suggests that in addition to higher viral load, low levels of CD4 binding site antibodies correlate with increased risk of HIV-1 vertical transmission. Passive immunotherapy with broadly neutralizing CD4 binding site antibodies should be considered as a strategy to reduce this risk.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 732
page 732
icon of scanned page 733
page 733
icon of scanned page 734
page 734
icon of scanned page 735
page 735
icon of scanned page 736
page 736
icon of scanned page 737
page 737
Version history
  • Version 1 (February 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts